Breast cancer is a heterogeneous group of diseases and hormone receptor status defines important clinical and etiologic differences between breast cancer subtypes. This article reviews the epidemiologic data on differences in risk factor associations by hormone receptor status, and highlights the limitations of commonly used prediction models. The authors describe how receptor status information can be applied to risk analysis for screening and preventive therapies.
- Wendy Y Chen
- Graham A Colditz
